BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17561962)

  • 1. Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity.
    Remmel N; Locatelli-Hoops S; Breiden B; Schwarzmann G; Sandhoff K
    FEBS J; 2007 Jul; 274(13):3405-20. PubMed ID: 17561962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes: patient variant Saposin A lacks lipid extraction capacity.
    Locatelli-Hoops S; Remmel N; Klingenstein R; Breiden B; Rossocha M; Schoeniger M; Koenigs C; Saenger W; Sandhoff K
    J Biol Chem; 2006 Oct; 281(43):32451-60. PubMed ID: 16905746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins.
    Linke T; Wilkening G; Lansmann S; Moczall H; Bartelsen O; Weisgerber J; Sandhoff K
    Biol Chem; 2001 Feb; 382(2):283-90. PubMed ID: 11308026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
    Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
    J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal degradation of membrane lipids.
    Kolter T; Sandhoff K
    FEBS Lett; 2010 May; 584(9):1700-12. PubMed ID: 19836391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K; Kolter T
    Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization.
    Wendeler M; Hoernschemeyer J; John M; Werth N; Schoeniger M; Lemm T; Hartmann R; Kessler H; Sandhoff K
    Protein Expr Purif; 2004 Mar; 34(1):147-57. PubMed ID: 14766311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
    Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
    Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.
    Kolter T; Sandhoff K
    Annu Rev Cell Dev Biol; 2005; 21():81-103. PubMed ID: 16212488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human saposins by NMR spectroscopy.
    John M; Wendeler M; Heller M; Sandhoff K; Kessler H
    Biochemistry; 2006 Apr; 45(16):5206-16. PubMed ID: 16618109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of saposin D with membranes: effect of anionic phospholipids and sphingolipids.
    Ciaffoni F; Tatti M; Salvioli R; Vaccaro AM
    Biochem J; 2003 Aug; 373(Pt 3):785-92. PubMed ID: 12733985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids.
    Werth N; Schuette CG; Wilkening G; Lemm T; Sandhoff K
    J Biol Chem; 2001 Apr; 276(16):12685-90. PubMed ID: 11278374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.
    Wilkening G; Linke T; Sandhoff K
    J Biol Chem; 1998 Nov; 273(46):30271-8. PubMed ID: 9804787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enzyme-binding region of human GM2-activator protein.
    Wendeler M; Werth N; Maier T; Schwarzmann G; Kolter T; Schoeniger M; Hoffmann D; Lemm T; Saenger W; Sandhoff K
    FEBS J; 2006 Mar; 273(5):982-91. PubMed ID: 16478472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of recombinant human saposin A expressed by Pichia pastoris.
    Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
    Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and cellular bases of sphingolipidoses.
    Sandhoff K
    Biochem Soc Trans; 2013 Dec; 41(6):1562-8. PubMed ID: 24256255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saposin C-LBPA interaction in late-endosomes/lysosomes.
    Chu Z; Witte DP; Qi X
    Exp Cell Res; 2005 Feb; 303(2):300-7. PubMed ID: 15652344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of vesicular stomatitis virus fusion by the endosome-specific phospholipid bis(monoacylglycero)phosphate (BMP).
    Roth SL; Whittaker GR
    FEBS Lett; 2011 Mar; 585(6):865-9. PubMed ID: 21333650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saposin C is required for lipid presentation by human CD1b.
    Winau F; Schwierzeck V; Hurwitz R; Remmel N; Sieling PA; Modlin RL; Porcelli SA; Brinkmann V; Sugita M; Sandhoff K; Kaufmann SH; Schaible UE
    Nat Immunol; 2004 Feb; 5(2):169-74. PubMed ID: 14716313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.